Sugar-binding protein galectin-1 could be a biomarker for patients at risk of life threatening sepsis
Vaccination campaign picks up speed around the world
4 January 2021No decision on Moderna vaccine on Monday: EU regulator
4 January 2021Sugar-binding protein galectin-1 could be a biomarker for patients at risk of life threatening sepsis
A sugar-binding protein could fuel terrible inflammation and worsen sepsis, a disease that kills more than 270,000 people every year in the US alone, reports a team of researchers led by UConn Health in the 4 January issue of Nature Immunology.
